SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-3,668 Cr | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-3,668 Cr |
| Mar2025 | ₹-4,215 Cr |
| Mar2024 | ₹-3,932 Cr |
| Mar2023 | ₹-3,487 Cr |
| Mar2022 | ₹-2,818 Cr |
How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3,668 Cr | Negative | |
| Mar2025 | ₹-4,215 Cr | Negative | |
| Mar2024 | ₹-3,932 Cr | Negative | |
| Mar2023 | ₹-3,487 Cr | Negative | |
| Mar2022 | ₹-2,818 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,220.9 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | -0.9% | 15.3% | 16.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% |
9.1% |
6.6% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses